the central line samples were seeded in blood agar, chocIn cancer patients the presence of immunosuppression by virtue of their disease, use of chemotherapy with associated olate agar, McConkey agar and thioglycolate for 48 h at 37°C in CO 2 enriched atmosphere appearing as abundant toxicity, frequent breaks in skin and mucosal barriers, treatment with broad-spectrum antibiotics and prolonged percolony-forming units of a non-fermentative gram-negative bacillus.
iods of neutropenia predispose to unusual opportunistic infections such as CDC group IV c-2. CDC group IV c-2 was identified. The bacillus appeared in six blood culture flasks, two central line swabs from the CDC group IV c-2 infection has not been described in solid tumour patients previously and should be suspected medial connections and in one endoluminal brushing from the medial key. The culture of the line tip removed on day when unusual non-fermentative gram-negative rods are found in microbiological cultures. Resistance to antibiotics, +7 was negative. Antibiotic susceptibility was carried out by agar disk diffusion and the MIC by the automatic such as aminoglycosides commonly used in neutropenic cancer patients is commonly reported. Its prognosis is good Microscan system (plaque microdilution). Antibiogram showed that it was resistant to ampicillin, cephalotin, when treated correctly, although in our case the fever did not resolve until the neutrophil count recovered. Clinicians aztreonam, aminoglycosides and amoxy-clavulanic, and sensitive to cefoxitin, cefotaxime, ceftazidime, imipenem, should be aware of potential pathogenicity of this gramnegative bacillus in neutropenic cancer patients. ticarcillin, piperacillin, trimethoprim-sulphamethoxazole and norfloxacin.
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